A study of nab-paclitaxel and gemcitabine with or without olaratumab for treatment of pancreatic cancer that has spread to other parts of the body

Update Il y a 4 ans
Reference: EUCTR2016-001099-31

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Phase Ib: To determine a recommended Phase 2 dose of olaratumab in combination with nab-paclitaxel and gemcitabine Phase II: To compare the efficacy of olaratumab plus nab-paclitaxel and gemcitabine with placebo plus gemcitabine and nab-paclitaxel


Inclusion criteria

  • First-Line Metastatic Pancreatic Cancer

Links